Rachel B Jimenez (Rachel Jimenez)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Advanced Cancer

Affordable Care Act

Top Venues

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas P Howard, Shearwood McClelland Iii, Rachel B Jimenez
Evolving Role of Proton Radiation Therapy in Clinical Practice. JCO oncology practice (2024)
Thomas P Howard, Shearwood McClelland Iii, Rachel B Jimenez
Evolving Role of Proton Radiation Therapy in Clinical Practice. JCO oncology practice 20 (6) (2024)
Thomas P Howard, Shearwood McClelland Iii, Rachel B Jimenez
Evolving Role of Proton Radiation Therapy in Clinical Practice. JCO oncology practice 20 (6) (2024)
Sienna M Durbin, Debra M Lundquist, Andrea Pelletier, Rachel B Jimenez, Laura A Petrillo, Janice S Kim, Kaitlyn Lynch, Megan Healy, Andrew E Johnson, Nicholas Ollila, Vaishnavi Yalala, Benjamin Malowitz, Allison M Kehlmann, Nicholas Chevalier, Victoria Turbini, Viola Bame, Hope Heldreth, Jenipher Silva, Casandra McIntyre, Dejan Juric, Ryan David Nipp
Time Toxicity Experienced by Early-Phase Cancer Clinical Trial Participants. JCO oncology practice (2024)
Alexandra Diaz Pardo, Harvey J Mamon, Rachel B Jimenez
Hypofractionation: Contracting or Expanding Disparities in the Receipt of Radiation Therapy? JCO oncology practice 19 (2) (2023)
Alexandra Diaz Pardo, Harvey J Mamon, Rachel B Jimenez
Hypofractionation: Contracting or Expanding Disparities in the Receipt of Radiation Therapy? JCO oncology practice 19 (2) (2023)
Alexandra Diaz Pardo, Harvey J Mamon, Rachel B Jimenez
Hypofractionation: Contracting or Expanding Disparities in the Receipt of Radiation Therapy? JCO oncology practice 19 (2) (2023)
Alexandra Diaz Pardo, Harvey J Mamon, Rachel B Jimenez
Hypofractionation: Contracting or Expanding Disparities in the Receipt of Radiation Therapy? JCO oncology practice (2023)
Debra M Lundquist, Rachel B Jimenez, Sienna M Durbin, Nora Horick, Megan Healy, Andrew E Johnson, Viola Bame, Virginia Capasso, Casandra McIntyre, Barbara Cashavelly, Dejan Juric, Ryan David Nipp
Identifying Early-Phase Clinical Trial Participants at Risk for Experiencing Worse Clinical Outcomes. JCO oncology practice (2023)
Rebecca A Spence, Leslie J Hinyard, Reshma Jagsi, Rachel B Jimenez, Ana Maria Lopez, Mariana Chavez Mac Gregor, Kayte Spector-Bagdady, Abby R Rosenberg
ASCO Ethical Guidance for the US Oncology Community Where Reproductive Health Care Is Limited by Law. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Alexandra Diaz Pardo, Harvey J Mamon, Rachel B Jimenez
Hypofractionation: Contracting or Expanding Disparities in the Receipt of Radiation Therapy? JCO oncology practice 19 (2) (2023)
Rachel B Jimenez, Caroline Schenkel, Laura A Levit, Bonnie Hu, Xiudong Jennifer Lei, Robert Donald Harvey, Vicki A Morrison, Teri Pollastro, David Michael Waterhouse, Colin Weekes, Grant R Williams, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Jeffrey M Peppercorn
Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic Cancer. JCO oncology practice 18 (11) (2022)
Kirti Magudia, Thomas S C Ng, Shauna R Campbell, Patricia Balthazar, Elizabeth H Dibble, Comron J Hassanzadeh, Neil Lall, Emily C Merfeld, Shadi A Esfahani, Rachel B Jimenez, Emma C Fields, Johnson B Lightfoote, Susan J Ackerman, Elizabeth B Jeans, Meridith J Englander, Carolynn M DeBenedectis, Kristin K Porter, Lucy B Spalluto, Lori A Deitte, Reshma Jagsi, Elizabeth Kagan Arleo
Family and Medical Leave for Diagnostic Radiology, Interventional Radiology, and Radiation Oncology Residents in the United States: A Policy Opportunity. Radiology 300 (1) (2021)
Andrew E Johnson, Suzanne B Coopey, Laura M Spring, Nora K Horick, Jose Pablo Leone, Nancy U Lin, Laura S Dominici, Kevin S Hughes, Rachel B Jimenez
Management and outcomes of men diagnosed with primary breast cancer. Breast cancer research and treatment 188 (2) (2021)